期刊文献+

房间隔缺损患者介入封堵术后血栓前高凝血状态的研究 被引量:4

Study of hypercoagulative state in patients after catheter closure of atrial septal defect
在线阅读 下载PDF
导出
摘要 目的研究房间隔缺损(ASD)患者介入关闭术后高凝血状态的机制及干预方法。方法观察82例ASD患者介入治疗前后抗凝血酶-III(antithrombin-III,AT-III)活性、纤维蛋白原(Fibrinogen,Fib)、D-二聚体(D-dimer,D-D)和组织型纤溶酶原激活物(tissue-type plasminogen activator,t-PA)水平的变化以及肝素对它们的影响作用。结果介入关闭ASD的患者术后30min,血浆AT-III活性较术前明显下降(P<0.01),Fib、D-D和t-PA浓度较术前明显升高(P均<0.01)。术后第3天,血浆AT-III活性较封堵术前和术后30min下降更加明显(P均<0.01);Fib和D-D浓度较术后30min明显下降(P<0.01),但仍明显高于封堵术前(P<0.01);血浆t-PA浓度较术前和术后30min明显下降(P均<0.01)。ASD封堵术后30min血浆Fib、D-D和t-PA浓度与心导管在心血管内的操作时间呈正相关(r分别为0.464、0.758和0.251。P<0.01,P<0.01,P<0.05)。术后应用低分子肝素3d的患者在术后第3d,血浆AT-III活性明显高于术后只应用1d低分子肝素的患者(P<0.01),Fib和D-D浓度明显低于术后只应用1d低分子肝素的患者(P均<0.01)。结论介入关闭ASD的患者术后抗凝血因子活性下降,促凝血因子活性增强,产生了高凝血状态,术后低分子肝素的应用可以减轻高凝血状态。 [Objective] This study sought to determine the mechanism and treatment of hypercoagulative state in patients after catheter closure of atrial septal defect (ASD). [Methods] We studied 82 patients undergoing catheter closure of ASD. The levels of antithrombin-III (AT-III), fibrinogen (Fib), D-dimer (D-D) and tissue-type plasminogen activator (t-PA) were measured before ASD closure, at the 30th minute and on the third day after ASD closure. The effect of hcparin on the levels of AT-III, Fib, D-D and t-PA were determined. [Results] At 30th minute after ASD closure there were significantly lower AT-III activity and higher levels of Fib, D-D and t-PA than those before ASD closure (P 〈0.01). AT-III activity and t-PA levels decreased significantly on the third day after ASD closure compared with those before ASD closure and at 30th minute after ASD (P 〈0.01). On the third day after ASD closure there were significantly lower levels of Fib and D-D than those at 30th minute after ASD closure (P 〈0.01) but higher levels of Fib and D-D than those before ASD closure (P 〈0.01). There was positive relationship between levels of Fib, D-D and t-PA and duration of catheter performance in vessel and heart (r was 0.464, 0.758 and 0.251 respectively. P 〈0.01,P 〈0.01,P 〈0.05). On the third day after ASD closure there were higher AT-III activity and lower levels of Fib and t-PA in patients treated with low-molecular-weight heparin for three days than those in patients treated with low-molecular-weight heparin for only one day (P 〈0.01). [Conclusions] There was a hypereoagulative state in patients for decreasing activation of anticoagulation and increasing activation of coagulation after catheter closure of ASD. The hypereoagulative state in patients after catheter closure of ASD could be relieved by treating with low-molecular-weight heparin.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第3期398-401,408,共5页 China Journal of Modern Medicine
基金 国家自然科学基金(No:30470709)
关键词 房间隔缺损 介入关闭 高凝血状态 atrial septal defect catheter closure hypercoagulative state
  • 相关文献

参考文献13

  • 1MASURA J, GAVORA P, PODNAR T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal oecluders [J]. J Am Coll Cardiol, 2005, 45: 505-507.
  • 2杨荣,孔祥清,盛燕辉,曹克将,许迪,陈明龙,秦建伟,陈亦江,陈广明,吴延虎,陈亮,骆金华.继发孔房间隔缺损的Amplatzer封闭器介入外科手术治疗的对比研究(英文)[J].中国现代医学杂志,2003,13(24):33-36. 被引量:10
  • 3DIVCHEV D, SCHAEFER A, FUCHS M, et al. Throw.bus formation on an atrial septal defect closure device: A ease report and review of the literature [J]. European Journal of Echocardiography, 2007, 8: 53-56.
  • 4CLARKE AC, HIRSCH KJ, KELLS CM, et al. Thrombus formation on an atrial septal defect closure device [J]. Can J Cardiol, 2005, 21: 68-70.
  • 5KRUMSDORF U, OSTERMAYER S, BILLINGER K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1 000 consecutive patients[J]. J Am Coll Cardiol, 2004, 43: 302-309.
  • 6WILLCOXSON FE, THOMSON JDIL GIBBS JL Suecessful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect oeeluder with abeiximab and heparin [J]. Heart, 2004, 90: 30-31.
  • 7DORBALA S, COHEN A J, radiofrequency ablation induce HUTCHINSON LA, et al. Does a prethrombotic state? Analysis of coagulation system activation and comparison to electrophysiologic study[J]. J Cardiovasc Electrophysiol, 1998, 9: 1152-1160.
  • 8CASSAR K, BACHOO P, FORD I, et al. Clopidogrel has no effect on D-dimer and thrombin-antithrombin IU levels in patients with peripheral arterial disease undergoing peripheral pereutaneoua transluminal angioplasty[J]. J Vase Surg, 2005, 42: 252-258.
  • 9MABCU CB, DONOHUE TJ, GHANTOUS AE, et al.Spontaneous aortic thrombosis and embolization: antithrombin deficiency and the work-up of hypercoagulable states [J]. CMAJ, 2005, 173: 1027-1029.
  • 10MAHMUD E, CAVENDISH JJ, TSIMIKAS S, et al. Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention[J]. J Am Coll Cardiol, 2007, 49: 2163-2171.

二级参考文献11

  • 1[1]Zhong-Dong Du,Hijazi,Kleinman,et al.Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults[J].J Am Coll Cardiol,2002,39:1836-1844.
  • 2[2]Masura J,Gavora P,Formanek A,et al.Transcatheter closure of secundun atrial septal defect using the new self-centering Amplatzer septal oecluder:initial human experience[J].Cather Cardiovasco Diagn,1997,42:388-393.
  • 3[3]Thanopoulos BD,Laskari CV,Tsaousis GS,et al.Closureof atrial septal defects with the Amplatzer occluder device:preliminary results[J].J Am Coll Cardiol,1998,31:1110-1116.
  • 4[4]Omeish A,Hijazi ZM.Transcatbeter closure of atrial septal defects in children and adults using the Amplatzer septal occluder[J].J Interv Cardiol,2001,14:37-44.
  • 5[5]Du ZD,Cao QL,Rhodes J,et al.Choice of device size and results of transcatheter closure of atrial septal defect using the amplatzer septal occluder[J].J Interv Cardiol,2002,15:287-292.
  • 6[6]Kong X,Cao K,Yang R,et al.Transcatheter closure of secundum atrial septal defect using an Amplatzer septal occluder[J].Chin Med J(Engl),2002,115:126-128.
  • 7[7]Collin G,Thomas R,Edward L,et al.Comparison of results of closure of secundum atrial septal defect by surgery versus Amplatzer septal occluder[J].Am J Cardiol,2001,88:589-591.
  • 8[8]Dai RP,Liu YL,Zhang GJ,et al.Evaluation of therapeutic efficacy of application of amplatzer septal occluder in atrial septal defect[J].Zhong Hua Xin Xue Guan Za Zhi,2000,28:87-92.
  • 9[9]Losay J,Petit J,Lambert V,et al.Percutaneous closure with Amplatzer device is a safe and efficient alternative to surgery in adults with large atrial septal defects[J].Am Heart J,2001,142:544-548.
  • 10[10]Formigari,Donato,Mazzera,et al.Minimally invasive or interventional repair of atrial septal defects in children:Experience in 171 cases and comparison with conventional strategies[J].J Am Coll Cardiol,2001,37:1707-1712.

共引文献540

同被引文献46

  • 1蒋世良,黄连军,徐仲英,赵世华,凌坚,郑宏,张戈军,张岩,戴汝平,刘延玲,王云.先天性心脏病介入治疗的严重并发症分析及其防治[J].中国循环杂志,2005,20(1):21-24. 被引量:100
  • 2刘萍,李效兰,杨萍.急性脑梗死患者血小板聚集率、抗凝血酶-Ⅲ和D-二聚体的变化[J].中国现代神经疾病杂志,2005,5(3):195-196. 被引量:4
  • 3张玉顺,代政学,王垒,李寰,张军,李军.边缘不足房间隔缺损的介入治疗评价[J].心脏杂志,2005,17(3):265-267. 被引量:15
  • 4邓东安,朱鲜阳,侯传举,韩秀敏.房间隔缺损介入治疗后随诊观察[J].中国介入影像与治疗学,2006,3(5):337-340. 被引量:6
  • 5Managle P,Chalmers E,Chan A,et al.Antithrombotic therapy in neonates and children:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest,2008,133 6 Supp1:887S-968S.
  • 6Hirsh J,Raschke R.Heparin and low-molecular-weight heparin:the.Seventh ACCP Confcrence on Antithrombotic and Thrombolytic Therapy.Chest,2004,126 3 Suppl:188S-203S.
  • 7Haas S,Breyer HG,Bacher HP,et al.Prevention of major venous thromboembolism following total hip or knee replacement:a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).Int Angiol,2006,25:335-342.
  • 8Ontalescot G,Polle V,Collet JP,et al.Low molecular weight heparin after mechanical heart valve replacement.Circulation,2000,101:1083-1086.
  • 9Bauman ME,Belletrutti MJ,Bajzar L,et al.Evaluation of enoxaparin dosing requirements in infants and children.Better dosing to achieve therapeutic levels.Thromb Haemost,2009,101:86-92.
  • 10De Candia E,De Cristofaro R,Landolfi R,et al.Thrombin-induced platelet activation is inhibited by high-and low-molecularweight heparin.Circulation,1999,99:3308-3314.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部